CIK 0001812364 · Large accelerated filer
Relay Therapeutics, Inc.
Sign in to watch- Ticker
- RLAY
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-370-8837
- Business address
- 60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $120,165,474
- in 11 filings, $3.7M under 10b5-1 plans
Net −$120,165,474. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-13 | Third Rock Ventures III, L.P. 10% owner | Sale | −4,782 | $44.73 | $214K | 1,965,294 |
| 2021-01-12 | Third Rock Ventures III, L.P. 10% owner | Sale | −1,500,000 | $40.00 | $60.0M | 9,051,115 |
| 2020-12-11 | Catinazzo Thomas Senior Vice President, Finance | Grant or award · Stock Option (Right to Buy) | +63,363 | 63,363 | ||
| 2020-12-11 | Bergstrom Donald A See Remarks | Grant or award · Stock Option (Right to Buy) | +126,727 | 126,727 | ||
| 2020-12-11 | Adams Brian General Counsel | Grant or award · Stock Option (Right to Buy) | +67,588 | 67,588 | ||
| 2020-12-11 | Patel Sanjiv President and CEO | Grant or award · Stock Option (Right to Buy) | +753,804 | 753,804 | ||
| 2020-07-20 | Third Rock Ventures III, L.P. 10% owner | Conversion | +9,970,454 | 9,970,454 | ||
| 2020-07-20 | Third Rock Ventures III, L.P. 10% owner | Conversion | +2,793,770 | 2,793,770 | ||
| 2020-07-20 | Third Rock Ventures III, L.P. 10% owner | Conversion | +17,427 | 9,987,881 | ||
| 2020-07-20 | Third Rock Ventures III, L.P. 10% owner | Conversion | +17,427 | 2,811,197 | ||
| 2020-07-20 | Third Rock Ventures III, L.P. 10% owner | Conversion · Series A Convertible Preferred Stock | −35,404,286 | 0 | ||
| 2020-07-20 | Third Rock Ventures III, L.P. 10% owner | Conversion · Series A Convertible Preferred Stock | −9,920,455 | 0 | ||
| 2020-07-20 | Third Rock Ventures III, L.P. 10% owner | Conversion · Series B Convertible Preferred Stock | −61,881 | 0 | ||
| 2020-07-20 | Third Rock Ventures III, L.P. 10% owner | Conversion · Series B Convertible Preferred Stock | −61,881 | 0 | ||
| 2020-07-20 | SVF Pauling (Cayman) Ltd 10% owner | Conversion | +27,904,963 | 27,904,963 | ||
| 2020-07-20 | SVF Pauling (Cayman) Ltd 10% owner | Conversion · Series C Convertible Preferred Stock | −99,088,292 | 0 | ||
| 2020-07-20 | Patel Sanjiv President and CEO | Purchase | +25,000 | $20.00 | $500K | 403,082 |
| 2020-07-20 | Murcko Mark Director | Conversion | +281,617 | 718,123 | ||
| 2020-07-20 | Murcko Mark Director | Conversion | +278,829 | 996,952 | ||
| 2020-07-20 | Murcko Mark Director | Purchase | +25,000 | $20.00 | $500K | 1,021,952 |
Page 26 of 27 · 534 trades